Imago Biosciences, Inc., A Subsidiary Of Merck & Co., Inc., (rahway, New Jersey Usa)

This study tested an experimental pill called bomedemstat in 20 people with polycythemia vera, a condition where the body makes too many red blood cells. The goal was to see if the drug could safely lower blood thickness without needing blood removal procedures. Participants took…

This study tested an experimental pill called Bomedemstat in 73 people with essential thrombocythemia, a blood disorder causing too many platelets. Participants had already tried at least one standard treatment without success. The main goals were to check safety and see if the d…

This study looked at the long-term safety and effectiveness of the drug bomedemstat in 81 people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Participants had already taken bomedemstat in an earlier study and continued treatment to see how well it cont…